United Pharmaceuticals   Report issue

For profit Phase 3
Founded: Paris France (1991)
Status: No NME R&D (1991)

Organization Overview

First Clinical Trial
2011
NCT01940068
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

United Pharmaceuticals

Active Ingredients

Drugs in Phase 3 Trials (1)

amino acids (Freamine) (2 trials)

Drugs in Other Trials (1)

locust bean gum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypersensitivity (Phase 3)

Milk Hypersensitivity (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2